<PAGE>
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
------------------------------------
FORM 8-K
------------------------------------
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
September 9, 1999 000-27078
- --------------------------------- -----------------------------
Date of Report (Commission File Number)
(Date of earliest event reported)
HENRY SCHEIN, INC.
(Exact name of registrant as specified in its charter)
Delaware 11-3136595
- ------------------------------- ---------------------------------------
(State or other jurisdiction of (I.R.S. Employer Identification Number)
incorporation or organization)
135 Duryea Road, Melville, NY 11747
-------------------------------------------------------------
(Address of Principal Executive Offices) (Zip Code)
(516) 843-5500
-------------------------------------------------------------
(Registrant's telephone number, including area code)
<PAGE>
- --------------------------------------------------------------------------------
- --------------------------------------------------------------------------------
ITEM 5. OTHER EVENTS.
On September 9, 1999, Henry Schein, Inc. issued the press release filed as
an Exhibit to this Current Report on Form 8-K with respect to the naming of
Michael Racioppi, Vice President and General Manager of Henry Schein's direct
marketing Medical Division, as interim President of Henry Schein's Medical
Group. Mr. Racioppi succeeds Bruce J. Haber who resigned as President of Henry
Schein's Medical Group and from Henry Schein's Board of Directors.
ITEM 7. FINANCIAL STATEMENTS, PRO FORMA FINANCIAL INFORMATION
AND EXHIBITS.
(a) Not applicable.
(b) Not applicable.
(c) Exhibits:
99. Press Release, dated September 9, 1999.
2
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, Henry
Schein, Inc. has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
HENRY SCHEIN, INC.
By: /s/Michael Ettinger
-------------------------------------
Name: Michael Ettinger
Title: Vice President and Associate
General Counsel
Date: September 9, 1999
3
<PAGE>
EXHIBIT INDEX
DOC. NO. DOCUMENT DESCRIPTION
99 Press Release, dated September 9, 1999.
<PAGE>
<PAGE>
Exhibit 99
[Henry Schein Letterhead]
FOR: Henry Schein, Inc.
CONTACT: Steven Paladino
Senior Vice President and
Chief Financial Officer
(516) 843-5500
FOR IMMEDIATE RELEASE Susan Vassallo
Manager, Investor
and Public Relations
(516) 843-5562
[email protected]
HENRY SCHEIN'S APPOINTS NEW HEAD OF MEDICAL GROUP
Melville, New York, September 9, 1999-Henry Schein, Inc. (Nasdaq:HSIC)
today announced that Michael Racioppi, Vice President and General Manager of the
direct marketing Medical Division, has been named as interim President of Henry
Schein's Medical Group. He succeeds Bruce J. Haber who has resigned effective
immediately as President of Henry Schein's Medical Group in order to pursue
other opportunities and personal interests. Mr. Haber has also resigned as a
member of Henry Schein's Board of Directors.
Stanley M. Bergman, Chairman, Chief Executive Officer and President of
Henry Schein, said, "Mike Racioppi has done an outstanding job in all of his
responsibilities and most recently as head of our direct marketing medical
business. In his seven years with Henry Schein, Mike has demonstrated the strong
leadership and entrepreneurial skills that have made Henry Schein an industry
leader."
Bruce Haber is to be thanked for his contributions in integrating Micro
Bio-Medics into Henry Schein's medical business, and overall for his
contribution to the Schein Medical Group. We wish him well in his future
endeavors, Mr. Bergman added.
Michael Racioppi joined Henry Schein, Inc. in 1992 as Senior Director,
Corporate Merchandising. In succeeding years, he was rapidly promoted to
additional positions of responsibility in both corporate merchandising and
marketing. He was appointed Vice President and General Manager of the direct
marketing Medical Division in 1998. He holds a bachelor's degree from the
University of Rhode Island and is a registered pharmacist.
Henry Schein, Inc. is the largest distributor of healthcare products and
services to office-based healthcare practitioners, including dental practices
and laboratories, physician practices and veterinary clinics. The Company,
recognized for its excellent customer service and low
<PAGE>
prices, serves more than 300,000 customers worldwide. Headquartered in Melville,
New York, the Company employs over 6,000 people in 16 countries. Sales in 1998
were $1.9 billion. For more information, visit the Henry Schein website at
http://www.henryschein.com.
Certain information contained herein includes information that is forward
looking. The matters referred to in forward looking statements may be affected
by the risks and uncertainties involved in the Company's business. These forward
looking statements are qualified in their entirety by the cautionary statements
contained in the Company's Securities and Exchange Commission filings.
###
<PAGE>
